Report Type
Single Stock Research Reports
Recent single stock reports highlight a recurring theme of solid top-line performance paired with aggressive strategic reinvestment, though varied operational headwinds are impacting near-term profitability across sectors. Veralto and Fluence Energy reported revenue largely in line with expectations, yet experienced contrasting margin outcomes; Veralto achieved a 24.6% operating margin beat, while Fluence's gross margins were compressed to 5.6% due to project-specific cost overruns. In the technology space, Alphabet’s massive AI build-out is reflected in 2026 Capex guidance of $175-185 billion, a shift that is forcing analysts to abandon free cash flow yield in favor of P/E and EBITDA valuation frameworks. Growth outlooks remain cautious, with Match Group signaling softer 2026 revenue due to regulatory costs and Veralto projecting moderate sales growth between LSD+ and MSD+. Macroeconomic risks are also tempering sentiment, as evidenced by downgrades for Harbour Energy driven by anticipated 2026 LNG oversupply and high leverage. Collectively, these reports underscore a market environment where robust demand and backlogs, such as Fluence’s $5.5 billion, must be weighed against rising capital intensity and shifting valuation metrics.
527 reports available
All reports
Page 20 of 22
Bank of China 1Q26 Post Result NDR Takeaways
Goldman Sachs · May 11, 2026
Apogee Therapeutics Analysis: Zumilokibart in Atopic Dermatitis
Goldman Sachs · May 11, 2026
MoonLake Immunotherapeutics 1Q26 Earnings Update
Goldman Sachs · May 11, 2026
Seronegative Approval Reinforces Vyvgart's MG Positioning
Goldman Sachs · May 11, 2026
Deutsche Bank Updating Estimates Post Q1 2026
Goldman Sachs · May 11, 2026
Clearwater Analytics Holdings 1Q26 EPS Update
Goldman Sachs · May 11, 2026
Evaluating Execution Risk for Avexitide Phase 3 Readout in Post-Bariatric Hypoglycemia
Goldman Sachs · May 11, 2026
LY Corp 4Q Earnings
Goldman Sachs · May 11, 2026
Firefly Aerospace Launch Progress
Goldman Sachs · May 11, 2026
Bath & Body Works Promotional Activity Update
Goldman Sachs · May 11, 2026
Samsung Biologics NDR Takeaway
Goldman Sachs · May 11, 2026
Vista Energy New 2026-30 Outlook Unveiled
Goldman Sachs · May 11, 2026
Cenomi Centers 1Q26 Earnings Call Takeaways
Goldman Sachs · May 11, 2026
Updating Estimates Post Q1 2026
Goldman Sachs · May 11, 2026
Embraer Continues Strong Revenue Growth and Margin Trajectory
Goldman Sachs · May 11, 2026
Leidos Holdings Solid Quarter
Goldman Sachs · May 11, 2026
Introduce Bepirovirsen From GSK to Enrich Hepatitis Portfolio
Goldman Sachs · May 11, 2026
1Q New Guidance Above Expectations: AI Capex Benefits Are Broadening
Goldman Sachs · May 11, 2026
Rockwool 1Q 2026 First Take
Goldman Sachs · May 11, 2026
Mosaic Q1 Results and Phosphate Production Curtailments
Goldman Sachs · May 11, 2026
Philip Morris International: ZYN Ultra Rollout Following FDA Guidance
Goldman Sachs · May 11, 2026
Hannover Re Data Update Following 1Q26 Results
Goldman Sachs · May 11, 2026
Investor Day: High Growth Portfolio Achieved Critical Mass
Goldman Sachs · May 11, 2026
Fox Corp F3Q26 Review EBITDA Beat
Goldman Sachs · May 11, 2026